BRADO eye drops

BRADO
Brimonidine tartrate 0.2%
BRADO is an antiglaucoma eye drops contains brimonidine tartrate 0.2%
Which is the only selective a2-adrenergic receptor agonist approved for
chronic treatment in glaucoma / Therapeutic Indications Reduction of As monotherapy In patients with open-argh glaucoma or When therapy

Share

Description

BRADO
Brimonidine tartrate 0.2%
BRADO is an antiglaucoma eye drops contains brimonidine tartrate 0.2%
Which is the only selective a2-adrenergic receptor agonist approved for
chronic treatment in glaucoma / Therapeutic Indications Reduction of As monotherapy In patients with open-argh glaucoma or When therapy